13 Mar MC Services to support BIO-Europe Spring® 2019 in Vienna as media partner
Munich/Düsseldorf, Germany, March 13, 2019. MC Services AG, the international public relations and investor relations firm, announced today that it will support, as a media partner, BIO-Europe Spring® 2019, Europe’s largest springtime partnering conference for the global life sciences industry. The event, organized by EBD Group, will take place from March 25-27, 2019 at the Messe Wien Exhibition and Congress Center, Vienna, Austria.
“BIO-Europe Spring®, the key springtime partnering conference of the European life sciences industry, provides an excellent platform to network with investors, partners, fellow industry executives and leading sector reporters,” said Raimund Gabriel, Managing Partner at MC Services. “With numerous journalists expected to attend this spring meeting in Vienna, we look forward to helping raise the global awareness of Austria’s vibrant biotech hub and the sector as a whole.”
As media partner, MC Services invites local and international journalists to the event and provides them with information on presenting companies, their executives and investors. Located right next to the exhibit hall and the registration desks, the BIO-Europe Spring® Press Lounge offers work space for accredited media representatives who will also be able to use the lounge area to conduct interviews or network with industry representatives.
BIO-Europe Spring® attracts an international “who’s who” from the biotech, pharma and finance sectors, along with the most exciting emerging companies. Based on previous years’ numbers, BIO-Europe Spring® 2019 is expected to draw over 2,500 pharma and biotech senior executives of more than 1,500 companies seeking valuable partnerships and investments, who will participate in a projected 15,000+ one-to-one meetings during the three-day conference. More than 100 company presentations and over 20 high-level workshops and panel discussions will round off the event. Furthermore, high-level speakers will share their experience and opinions on digital medicine, underserved therapeutic areas, newly emerging partnering models, as well as the recent trends in the Asia-Pacific biotech markets and the European biotech investment community. For detailed information regarding the program, timing and location, please visit the event’s website.